Ergonovine Maleate Injection
»Ergonovine Maleate Injection is a sterile solution of Ergonovine Maleate in Water for Injection.It contains not less than 90.0percent and not more than 110.0percent of the labeled amount of C19H23N3O2·C4H4O4.
Packaging and storage— Preserve in single-dose,light-resistant containers,preferably of Type Iglass,and store in a cold place.
Identification— The RFvalue of the principal blue spot obtained from the Test preparationcorresponds to that obtained from Standard preparation Ain the chromatogram prepared as directed in the test for Related alkaloids.
Bacterial endotoxins á85ñ It contains not more than 700.0USP Endotoxin Units per mg of ergonovine maleate.
pHá791ñ: between 2.7and 3.5.
Related alkaloids— [NOTE—Conduct this test promptly,without exposure to daylight and with minimum exposure to artificial light.]
Solvent mixture,Standard preparation,and Standard dilutions Prepare as directed in the test for Related alkaloidsunder Ergonovine Maleate.
Test preparation— Immediately prior to use,transfer a volume of Injection,equivalent to about 5mg of ergonovine maleate,to a separator,and extract with three 5-mLportions of chloroform.Discard the chloroform extracts.Render alkaline to litmus with 6Nammonium hydroxide,and extract with three 5-mLportions of chloroform.Evaporate the combined extracts with the aid of a stream of nitrogen,but without heat,to dryness.Dissolve the residue so obtained in 0.5mLof Solvent mixture.
Procedure— Proceed as directed for Procedurein the test for Related alkaloidsunder Ergonovine Maleate.
Other requirements— It meets the requirements under Injections á1ñ.
Assay—
0.05M Phosphate buffer— Dissolve 6.8g of monobasic potassium phosphate in 600mLof water and adjust with phosphoric acid to a pHof 2.1.Dilute with water to 1000mL,and mix.
Mobile phase— Prepare a suitable and degassed solution of 0.05M Phosphate bufferand acetonitrile (80:20)such that the retention time is approximately 3minutes with a flow rate of 1mLper minute.
Standard preparation— Dissolve an accurately weighed quantity of USP Ergonovine Maleate RSin Mobile phase,adding sufficient water to equal 10%of the final volume,to obtain a solution having a known concentration of about 0.02mg per mL.
Assay preparation— Quantitatively dilute an accurately measured volume of the Injection,equivalent to about 2mg of ergonovine maleate,with Mobile phaseand water,if necessary,to obtain a solution having a concentration of about 0.02mg per mLin which the Injection volume plus any added water constitutes 10%of the final volume.
Chromatographic system (see Chromatography á621ñ)—The liquid chromatograph is equipped with a 312-nm detector and a 3-mm ×30-cm column that contains packing L1.Chromatograph five replicate injections of the Standard preparation,and record the peak responses as directed under Procedure:the relative standard deviation is not more than 3.0%.
Procedure— By means of a suitable sampling valve,introduce equal volumes (about 100µL)of the Assay preparationand the Standard preparationinto the chromatograph.Measure the peak responses of Ergonovine Maleate,at corresponding retention times,obtained from the Assay preparationand the Standard preparation.Calculate the quantity,in mg,of C19H23N3O2·C4H4O4in each mLof the Injection taken by the formula:
(CD/V)(rU/rS),
in which Cis the concentration,in mg per mL,of USP Ergonovine Maleate RSin the Standard preparation,Vis the volume,in mL,of Injection taken,Dis the dilution factor,and rUand rSare the peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Clydewyn M.Anthony,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28–NF23Page 751
Phone Number:1-301-816-8139